Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nystatin 100,000units/ml oral suspension
0502030B0AAABAB
|
Nystatin (Systemic) | Nystatin | Infections | 168,397 |
|
Nystan 100,000units/ml oral suspension (ready mixed)
0502030B0BBABAB
|
Nystan (Systemic) | Nystatin | Infections | 54,689 |
|
Nystaform cream
1310020U0BCAAAE
|
Nystaform | Nystatin | Skin | 664 |
|
Nystatin 100,000units/g / Chlorhexidine hydrochloride 1% crm
1310020U0AAAEAE
|
Nystatin (Topical) | Nystatin | Skin | 623 |
|
Nystatin 100,000units/ml oral suspension sugar free
0502030B0AAAXAX
|
Nystatin (Systemic) | Nystatin | Infections | 146 |
|
Nystatin 100,000unit pessaries
0702020T0AAAFAF
|
Nystatin (Vaginal) | Nystatin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 144 |
|
Nystatin 100,000units/g cream
1310020U0AAAAAA
|
Nystatin (Topical) | Nystatin | Skin | 14 |
|
Nystan 100,000units/g cream
1310020U0BDAAAA
|
Nystan (Topical) | Nystatin | Skin | 1 |
|
Nystamont 100,000units/ml oral suspension
0502030B0BGAAAX
|
Nystamont | Nystatin | Infections | No data available |
|
Nystan 100,000unit pastilles
1203020N0BBAAAA
|
Nystan (Mouthwash) | Nystatin | Ear, Nose and Oropharynx | No data available |
|
Nystan 100,000unit pessaries
0702020T0BCACAF
|
Nystan (Vaginal) | Nystatin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Nystan 100,000units/4g application vaginal cream
0702020T0BCABAE
|
Nystan (Vaginal) | Nystatin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Nystan 100,000units/g ointment
1310020U0BDACAD
|
Nystan (Topical) | Nystatin | Skin | No data available |
|
Nystan 500,000unit tablets
0502030B0BBAAAI
|
Nystan (Systemic) | Nystatin | Infections | No data available |
|
Nystatin 100,000unit pastilles
1203020N0AAAAAA
|
Nystatin (Mouthwash) | Nystatin | Ear, Nose and Oropharynx | No data available |
|
Nystatin 100,000units/4g application vaginal cream
0702020T0AAAEAE
|
Nystatin (Vaginal) | Nystatin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Nystatin 100,000units/g / Tolnaftate 1% cream
1310020U0AAAGAG
|
Nystatin (Topical) | Nystatin | Skin | No data available |
|
Nystatin 100,000units/g ointment
1310020U0AAADAD
|
Nystatin (Topical) | Nystatin | Skin | No data available |
|
Nystatin 250mg capsules
0502030B0AAAKAK
|
Nystatin (Systemic) | Nystatin | Infections | No data available |
|
Nystatin 500,000unit tablets
0502030B0AAAIAI
|
Nystatin (Systemic) | Nystatin | Infections | No data available |
|
Nystatin powder
0502030B0AAACAC
|
Nystatin (Systemic) | Nystatin | Infections | No data available |
|
Tinaderm-M cream
1310020U0BEAAAG
|
Tinaderm-M | Nystatin | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.